- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Eikon excels at $518m series B
Eikon Therapeutics was co-founded by UC Berkeley researchers, one of whom has already received a Nobel Prize for the underlying technology.
Jan 11, 2022Daily Deal Round Up: January 10, 2022
Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.
Jan 10, 2022Exits: January 10, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Jan 10, 2022Deals: January 10, 2022
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Jan 10, 2022Korro Bio concludes $116m series B
All existing shareholders including Alexandria Venture Investments contributed to the RNA drug developer’s series B round, following a $91.5m series A in mid-2020.
Jan 10, 2022Korro Bio concludes $116m series B
All existing shareholders contributed to the Marine Biological Laboratory spinout’s series B round, following a $91.5m series A in mid-2020.
Jan 10, 2022Analysis: Venturing activity spiked in 2021
2021 registered record figures in the realm of corporate venturing.
Jan 10, 2022Daily Deal Round Up: January 7, 2022
Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.
Jan 7, 2022Daily Deal Round Up: January 6, 2022
Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.
Jan 6, 2022Industry embarks on fifth revolution
The digital transformation that has disrupted and reshaped the industrial sector in recent years, known as the fourth industrial revolution or industry 4.0, has now reached a new chapter with the development of what has been dubbed as industry 5.0.
Jan 6, 2022Daily Deal Round Up: January 4, 2022
Veon and Prosus helped B2B product marketplace ShopUp push its series B funding to $109m while Sunshine Insurance backed rounds for ImmuneOnco and Xuanzhu Biopharmaceutical.
Jan 4, 2022Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


